microRNAs at the regulatory frontier: An investigation into how microRNAs impact the development and effector functions of CD4 T cells

Immunologic Research

Volumn 49, Issue 1-3, 2011, Pages 87-96

  Lykken, Erik Allen ^a   Li, Qi Jing ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Cancer immunity; Immunoregulation; microRNA; T cells

Indexed keywords

MICRORNA; MICRORNA 17-92; MICRORNA 181A; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; GENE CLUSTER; GENE EXPRESSION REGULATION; GROWTH REGULATION; IMMUNOREGULATION; INTRACELLULAR SIGNALING; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TUMOR PROMOTION;

ADAPTIVE IMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; MICRORNAS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION;

EID: 79952703781     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-010-8196-4     Document Type: Review

References (76)

1. Davis MM, et al. T cells as a self-referential, sensory organ. Annu Rev Immunol. 2007;25:681-95. (Pubitemid 46697921)
2. Kane LP, Lin J, Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol. 2000;12:242-9. (Pubitemid 30240532)
3. Vang T, et al. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol. 2008;26:29-55. (Pubitemid 351600370)
4. Samelson, L.E.: Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins. Annu Rev Immunol 2002; 20: 371-394.
5. Shaw AS, Filbert EL. Scaffold proteins and immune-cell signalling. Nat Rev Immunol. 2009;9:47-56.
6. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351-79.
7. Chen CZ, Li L, Lodish HF, Bartel DP. microRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83-6. (Pubitemid 38055775)
8. Li QJ, et al. miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection. Cell. 2007;129:147-61.
9. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. microRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9:839-45. (Pubitemid 352038302)
10. Matsui K, Boniface JJ, Steffner P, Reay PA, Davis MM. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA. 1994;91:12862-6.
11. Davis MM, et al. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol. 1998;16:523-44. (Pubitemid 28183375)
12. Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity. 2003;18:255-64. (Pubitemid 36263000)
13. Holler PD, Kranz DM. T cell receptors: affinities, cross-reactivities, and a conformer model. Mol Immunol. 2004;40:1027-31. (Pubitemid 38221182)
14. Evavold BD, Allen PM. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science. 1991;252:1308-10. (Pubitemid 21917045)
15. Evavold BD, Sloan-Lancaster J, Allen PM. Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand. Proc Natl Acad Sci USA. 1994;91:2300-4. (Pubitemid 24092091)
16. Krogsgaard M, et al. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature. 2005;434:238-43. (Pubitemid 40388057)
17. Pircher H, Rohrer UH, Moskophidis D, Zinkernagel RM, Hengartner H. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature. 1991;351:482-5. (Pubitemid 21896624)
18. Davey GM, et al. Preselection thymocytes are more sensitive to T cell receptor stimulation than mature T cells. J Exp Med. 1998;188:1867-74. (Pubitemid 28536774)
19. Lucas B, Stefanova I, Yasutomo K, Dautigny N, Germain RN. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity. 1999;10:367-76. (Pubitemid 29165291)
20. Curtsinger JM, Lins DC, Mescher MF. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J Immunol. 1998;160:3236-43. (Pubitemid 28164712)
21. Hogquist KA, et al. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17-27. (Pubitemid 24035278)
22. Kao H, Allen PM. An antagonist peptide mediates positive selection and CD4 lineage commitment of MHC class II-restricted T cells in the absence of CD4. J Exp Med. 2005;201:149-58. (Pubitemid 40130092)
23. Irvine DJ, Purbhoo MA, Krogsgaard M, Davis MM. Direct observation of ligand recognition by T cells. Nature. 2002;419:845-9. (Pubitemid 35238571)
24. Li QJ, et al. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat Immunol. 2004;5:791-9.
25. Purbhoo MA, Irvine DJ, Huppa JB, Davis MM. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol. 2004;5:524-30. (Pubitemid 38660465)
26. Ebert PJ, Ehrlich LI, Davis MM. Low ligand requirement for deletion and lack of synapses in positive selection enforce the gauntlet of thymic T cell maturation. Immunity. 2008;29:734-45.
27. Tarakhovsky A, et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science. 1995;269:535-7.
28. Starr TK, Daniels MA, Lucido MM, Jameson SC, Hogquist KA. Thymocyte sensitivity and supramolecular activation cluster formation are developmentally regulated: a partial role for sialylation. J Immunol. 2003;171:4512-20. (Pubitemid 37310566)
29. Zikherman J, et al. CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development. Immunity. 2010;32:342-54.
30. Wu J, et al. Identification of substrates of human protein-tyrosine phosphatase PTPN22. J Biol Chem. 2006;281:11002-10. (Pubitemid 43855523)
31. Zikherman J, et al. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J Immunol. 2009;182:4093-106.
32. Koelsch U, Schraven B, Simeoni L. SIT and TRIM determine T cell fate in the thymus. J Immunol. 2008;181:5930-9.
33. Theodosiou, A. & Ashworth, A.: MAP kinase phosphatases. Genome Biol 2002; 3: REVIEWS3009.
34. Ebert, P.J., Jiang, S., Xie, J., Li, Q.J. & Davis, M.M.: An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol 2009.
35. Liu G, Min H, Yue S, Chen CZ. Pre-miRNA loop nucleotides control the distinct activities of mir-181a-1, mir-181c in early T cell development. PLoS One. 2008;3:e3592.
36. Yamasaki S, et al. Mechanistic basis of pre-T cell receptor-mediated autonomous signaling critical for thymocyte development. Nat Immunol. 2006;7:67-75. (Pubitemid 41823870)
37. Stefanski HE, Mayerova D, Jameson SC, Hogquist KA. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo. J Immunol. 2001;166:6602-7. (Pubitemid 32467200)
38. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005;5:772-82. (Pubitemid 41400851)
39. Reddy J, et al. Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramers. J Immunol. 2003;170:870-7. (Pubitemid 36070540)
40. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW. Autoreactive T cells in healthy individuals. J Immunol. 2004;172:5967-72. (Pubitemid 38621196)
41. Goodnow, C.C.: Multistep pathogenesis of autoimmune disease. Cell 2007; 130: 25-35.
42. Bielekova B, et al. Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis. J Immunol. 2004;172:3893-904. (Pubitemid 38337977)
43. Amrani A, et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature. 2000;406:739-42.
44. Savage PA, Boniface JJ, Davis MM. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity. 1999;10:485-92. (Pubitemid 29205484)
45. Tian J, Gregori S, Adorini L, Kaufman DL. The frequency of high avidity T cells determines the hierarchy of determinant spreading. J Immunol. 2001;166:7144-50. (Pubitemid 32525585)
46. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol. 2007;25:171-92. (Pubitemid 46697906)
47. van Leeuwen EM, Sprent J, Surh CD. Generation and maintenance of memory CD4(+) T Cells. Curr Opin Immunol. 2009;21:167-72.
48. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol. 2010;28:445-89.
49. Curtale G, et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood. 2010;115:265-73.
50. Lu LF, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010;142:914-29.
51. Niimoto T, et al. microRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord. 2010;11:209.
52. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA. 2007;104:7080-5. (Pubitemid 47186012)
53. Almanza G, et al. Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One. 2010;5:e11243.
54. Rodriguez A, et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608-11. (Pubitemid 46683148)
55. Thai TH, et al. Regulation of the germinal center response by microRNA-155. Science. 2007;316:604-8.
56. Marson A, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature. 2007;445:931-5.
57. Zheng Y, et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature. 2007;445:936-40.
58. Lu LF, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity. 2009;30:80-91.
59. Kohlhaas S, et al. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol. 2009;182:2578-82.
60. Tanzer A, Stadler PF. Molecular evolution of a microRNA cluster. J Mol Biol. 2004;339:327-35. (Pubitemid 38596952)
61. Ota A, et al. EIdentification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 2004;64:3087-95. (Pubitemid 38581408)
62. He L, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828-33. (Pubitemid 40839734)
63. Ventura A, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132:875-86. (Pubitemid 351312807)
64. Xiao C, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008;9:405-14. (Pubitemid 351405110)
65. Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer. 2010;127:759-67.
66. Olive V, Jiang I, He L. Mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol. 2010;42:1348-54.
67. Castellano L, et al. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA. 2009;106:15732-7.
68. Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. Alterations in microRNA expression in stress-induced cellular senescence. Mech Ageing Dev. 2009;130:731-41.
69. Yan HL, et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 2009;28:2719-32.
70. Zhang Y, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010;39:133-44.
71. Baek, D. et al.: The impact of microRNAs on protein output. Nature 2008.
72. Selbach, M. et al.: Widespread changes in protein synthesis induced by microRNAs. Nature 2008.
73. Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature. 2009;460:479-86.
74. Krutzfeldt J, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005;438:685-9.
75. Thum, T. et al.: MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008.
76. Kota J, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137:1005-17.